Reed Elsevier PLC
25 February 2003
Letter to RNS
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
Director's interests
We are writing to advise you that we received notifications today that the
following grants of options were made to directors of Reed Elsevier PLC and
Reed Elsevier NV on 21 February 2003, under the Reed Elsevier Group plc
Executive Share Option Scheme:
Director No. of Reed No. of Reed Exercisable
Elsevier PLC Elsevier NV
shares over which shares over which
an option has been an option has been
granted at 451.5p per granted at Euro9.34
share per share
C H L Davis 209,192 148,946 2006-2013
M H Armour 104,319 74,276 2006-2013
G J A van de Aast 81,728 58,191 2006-2013
D J Haank 93,231 66,381 2006-2013
A Proves 132,142 94,086 2006-2013
Exercise of the above options is subject to the earnings per share
performance conditions, as described in the company's Annual Reports and
Financial Statements.
Letter from REED ELSEVIER PLC
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.